| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.28 | 0.007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.008 |